Free Trial

Augmedix Q2 2023 Earnings Report

Augmedix logo
$2.35 0.00 (0.00%)
(As of 10/2/2024)

Augmedix EPS Results

Actual EPS
-$0.12
Consensus EPS
-$0.13
Beat/Miss
Beat by +$0.01
One Year Ago EPS
N/A

Augmedix Revenue Results

Actual Revenue
$10.78 million
Expected Revenue
$10.41 million
Beat/Miss
Beat by +$370.00 thousand
YoY Revenue Growth
N/A

Augmedix Announcement Details

Quarter
Q2 2023
Time
N/A
This Crypto Is Set to Explode in December (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

Augmedix Earnings Headlines

Did You See Trump’s Bombshell Exec. Order 001?
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
See More Augmedix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Augmedix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Augmedix and other key companies, straight to your email.

About Augmedix

Augmedix (OTCMKTS:AUGX) provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

View Augmedix Profile

More Earnings Resources from MarketBeat

Upcoming Earnings